Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Fish and Richardson
Harvard Business School
McKesson
Queensland Health
US Army
AstraZeneca
Chubb
Medtronic
Healthtrust

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205175

« Back to Dashboard

NDA 205175 describes ECOZA, which is a drug marketed by Chemo Research Sl and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the ECOZA profile page.

The generic ingredient in ECOZA is econazole nitrate. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the econazole nitrate profile page.
Summary for 205175
Tradename:ECOZA
Applicant:Chemo Research Sl
Ingredient:econazole nitrate
Patents:1
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Pharmacology for NDA: 205175
Ingredient-typeAzoles
Medical Subject Heading (MeSH) Categories for 205175
Suppliers and Packaging for NDA: 205175
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ECOZA econazole nitrate AEROSOL, FOAM;TOPICAL 205175 NDA Exeltis USA Dermatology, LLC 23710-100 23710-100-10 1 CAN in 1 CARTON (23710-100-10) > 10 g in 1 CAN
ECOZA econazole nitrate AEROSOL, FOAM;TOPICAL 205175 NDA Exeltis USA Dermatology, LLC 23710-100 23710-100-70 1 CAN in 1 CARTON (23710-100-70) > 70 g in 1 CAN

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength1%
Approval Date:Oct 24, 2013TE:RLD:Yes
Regulatory Exclusivity Expiration:Oct 24, 2016
Regulatory Exclusivity Use:NEW DOSAGE FORM
Patent:➤ SubscribePatent Expiration:Jan 16, 2018Product Flag?YSubstance Flag?Delist Request?
Patented Use:METHOD OF ALLEVIATING A SKIN CONDITION

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Argus Health
Dow
Federal Trade Commission
Mallinckrodt
Baxter
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot